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Orphan Transporter SLC6A18 Is Renal Neutral Amino Acid
Transporter B0AT3
Abstract
The orphan transporter Slc6a18 (XT2) is highly expressed at the luminal membrane of kidney proximal
tubules and displays approximately 50% identity with Slc6a19 (B(0)AT1), which is the main neutral
amino acid transporter in both kidney and small intestine. As yet, the amino acid transport function of
XT2 has only been experimentally supported by the urinary glycine loss observed in xt2 null mice. We
report here that in Xenopus laevis oocytes, co-expressed ACE2 (angiotensin-converting enzyme 2)
associates with XT2 and reveals its function as a Na(+)- and Cl(-)-de pend ent neutral amino acid
transporter. In contrast to its association with ACE2 observed in Xenopus laevis oocytes, our
experiments with ace2 and collectrin null mice demonstrate that in vivo it is Collectrin, a smaller
homologue of ACE2, that is required for functional expression of XT2 in kidney. To assess the function
of XT2 in vivo, we reanalyzed its knock-out mouse model after more than 10 generations of
backcrossing into C57BL/6 background. In addition to the previously published glycinuria, we observed
a urinary loss of several other amino acids, in particular beta-branched and small neutral ones. Using
telemetry, we confirmed the previously described link of XT2 absence with hypertension but only in
physically restrained animals. Taken together, our data indicate that the formerly orphan transporter
XT2 functions as a sodium and chloride-de pend ent neutral amino acid transporter that we propose to
rename B(0)AT3.
SLC6A18 is neutral amino acid transporter B0AT3 
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The orphan transporter Slc6a18 (XT2) is 
highly expressed at the luminal membrane of 
kidney proximal tubules and displays ~50% 
identity with Slc6a19 (B0AT1) which is the main 
neutral amino acid transporter in both kidney 
and small intestine. As yet, the amino acid 
transport function of XT2 had only been 
experimentally supported by the urinary 
glycine loss observed in xt2 null mice. We 
report here that in Xenopus laevis oocytes, co-
expressed angiotensin-converting enzyme 2 
(ACE2) associates with XT2 and reveals its 
function as a Na+- and Cl--dependant neutral 
amino acid transporter. In contrast to its 
association with ACE2 observed in Xenopus 
laevis oocytes, our experiments with ace2 and 
collectrin null mice demonstrate that in vivo it is 
Collectrin, a smaller homologue of ACE2, that 
is required for functional expression of XT2 in 
kidney. To assess the function of XT2 in vivo, 
we re-analysed its knock-out mouse model after 
more than 10 generations of backcrossing into 
C57BL/6 background. In addition to the 
previously published glycinuria, we observed a 
urinary loss of several other amino acids, in 
particular beta-branched and small neutral 
ones. Using telemetry, we confirmed the 
previously described link of XT2 absence with 
hypertension, but only in physically restrained 
animals. Taken together, our data indicate that 
the formerly orphan transporter XT2 functions 
as a sodium and chloride dependent neutral 
amino acid transporter that we propose to 
rename B0AT3. 
 
The SLC6 family is composed of a variety of 
transporters that transfer small organic solutes such 
as neurotransmitters and amino acids across the 
plasma membrane. These substrates are co-
transported with sodium and in many cases also 
with chloride. The substrates transported by most 
of the different family members have been 
identified and include neurotransmitters 
((nor)epinephrine, dopamine, serotonin, GABA), 
osmolytes (taurine, creatinine) and amino acids. 
Despite this extensive characterisation, no data 
directly demonstrating the function of XT2 
(Slc6a18) in an expression system has been 
reported. In particular, the expression of XT2 in 
Xenopus laevis oocytes and cultured mammalian 
cells failed to result in uptake of a variety of tested 
substrates (1,2). 
However, XT2 exhibits approximately 50% 
identity to B0AT1 (Slc6a19), the Na+ cotransporter 
of neutral amino acids the defect of which causes 
Hartnup disorder. The XT2 gene is arranged in 
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tandem with that of B0AT1 (Slc6a19) on 
chromosome 5 in human and chromosome 13 in 
mouse, and thus presumably arose by gene 
duplication. A cloning study identified, besides the 
A12 isoform that resembles most the other Slc6 
family members, five shorter transcripts the 
physiological significance of which is not 
established (1). In a localization study performed 
using mouse tissues, we have shown that XT2 is 
mainly expressed in the kidney, where it localises 
to the brush border membrane of the late proximal 
tubule (S2, S3), in a complementary fashion to 
B0AT1 that localises to the early proximal tubule 
(S1) (3). 
A xt2 null mouse model was generated and 
analyzed previously (2). The high amounts of 
glycine found in the urine of these mice supported 
the hypothesis that the orphan gene product XT2 
functions as an amino acid transporter. 
Measurements of uptake in brush border 
membrane vesicles additionally demonstrated its 
function as a high affinity transport system of 
glycine. Surprisingly, the xt2 null mice displayed a 
systolic blood pressure that was 15 - 20 mmHg 
higher than that of their wild-type littermates, a 
difference that was abolished upon glycine 
supplementation in drinking water. Such an impact 
of XT2 on blood pressure was however not 
confirmed in human, where a SNP within the 
SLC6A18 gene present in 46.7% of a general 
Japanese population corresponds to a nonsense 
mutation (Y319X) presumably leading to a loss of 
function, and is not associated with hypertension 
(4). 
We have recently demonstrated that in the 
proximal kidney tubule, the expression of Slc6 B0 
cluster amino acid transporters requires their 
association with Collectrin (Tmem27, Coll), a 
membrane protein homologous to the membrane 
anchor domain of the renin angiotensin system 
enzyme ACE2 (5). Furthermore, we have shown 
that the enzyme ACE2, highly expressed in kidney 
and intestine, plays the role of associated protein in 
small intestine for luminal Slc6 amino acid 
transporters (6). 
The first aim of the present study was 
therefore to retest the function of XT2 in the X. 
laevis expression system using co-expression of 
both the kidney and the small intestine associated 
proteins Coll and ACE2, and second, to retest the 
impact of the absence of XT2 in the xt2 null mouse 
model after backcrossing it more than 10 times 
into C57BL/6 background. It appears, based on 
telemetric measurements, that XT2 is involved in 
blood pressure control only under stress conditions 
in the C57BL/6 background. We show in this 
study that the product of Slc6a18 called XT2 is a 
Na+- and Cl--dependent neutral amino acid 
transporter and displays, compared to B0AT1, a 
lower K0.5 and a different substrate selectivity. 
Because of its broad transport selectivity for 
neutral amino acids we suggest to rename it 
B0AT3. 
 
Experimental Procedures 
 
cRNA preparation of mouse XT2, Collectrin 
and ACE2 - The constructs of the A12 isoform of 
mouse XT2-KSM, Collectrin-pcDNA3.1Hygro 
and ACE2-pcDNA3 were linearized and used as 
template for RNA synthesis (mMESSAGE 
mMACHINE, Ambion, Austin, Texas, USA). 
Transport studies in X. leavis oocytes- 
Expression studies and uptake measurements in X. 
leavis oocytes were performed as described 
previously (7). Ten minutes uptakes were 
performed with buffer containing 0.1 mM of the 
corresponding L-AA (2 uCi 14C-L-AA / ml or 20 
uCi 3H-L-AA / ml). All experiments were done in 
buffer containing NaCl (100 mM) or NMDG-Cl 
(100 mM) for ion dependency experiments. 
Chloride was substituted by corresponding 
gluconate (Glc) salts. Kinetics experiments were 
performed with increasing concentrations of L-Ile 
(0.01, 0.03, 0.1, 0.3, and 1 mM) or L-Gly (0.01, 
0.1, 0.3, 1, and 3 mM), in the presence of NaCl. 
Data is expressed in pmol / h / oocyte and values 
obtained for non-injected oocytes are subtracted. 
Multiple comparisons within groups were 
performed by repeated-measures one way 
ANOVA, followed by Tukey post test. 
Animals - The xt2, ace2 and collectrin wild-
type and knock-out mice were housed in standard 
conditions and fed a standard diet. Generation of 
the knock-out mice was described elsewhere 
(2,5,8). All procedures for mice handling were 
according to the Swiss Animal Welfare laws and 
approved by the Kantonales Veterinäramt Zürich. 
Metabolic Cages - Animals were adapted to 
metabolic cages (Tecniplast, Buguggiate, Italy) for 
3 days before data collection, where they had free 
access to standard mouse diet (18.5% crude 
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protein, Kliba-Nafag, Kaiseraugst, Switzerland) 
and drinking water. After a first day of data 
collection in standard conditions, the diet was 
either switched to low protein (<0.5% crude 
protein, Kliba-Nafag) for two days or water access 
was removed for 24 h. Daily food/water intake, 
urine/feces output and body weights were 
measured. Urinary pH was measured using a pH 
microelectrode (691 pH-meter, Metrohm). Urinary 
creatinine was measured by the Jaffe method (9). 
Urinary electrolytes (Na+, K+, Ca2+, Mg2+, Cl-, 
SO42-) were measured by ion chromatography 
(Metrohm ion chromatograph, Herisau, 
Switzerland). 
Amino acid analysis - Mouse blood was 
collected by decapitation and 1 μl of heparin-Na+ 
25000 I.E./5 ml (B. Braun, Melsungen, Germany) 
was added. Plasma was collected after 
centrifugation at 5900 g and 4°C. Ice-cold 
methanol deproteinization of the plasma was 
performed as described elsewhere (10). Hundred 
microliters of deproteinised sample was dried and 
resuspended in 45 μl of borate buffer. Samples 
were then derivatized using AccQ Tag (Waters, 
Milford, USA) and analyzed on an Acquity UPLC 
(Waters) according to the manufacturers 
instructions by the Functional Genomics Center 
Zurich (FGCZ) (11). 
One microliter mouse urine collected over 24 h 
was diluted up to 100 μl by 50 mM HCl containing 
the internal standards norvaline and sarcosine in a 
concentration of 50 pmol/μl. The solutions were 
centrifuged, and transferred into new hydrolysing 
tube. One microliter was injected for pre-column 
derivatization with ortho-phthaldialdehyde (OPA) 
and analyzed on an Amino Quant amino acid 
analyzer (Agilent Technologies GmbH, Böblingen, 
Germany) at the Functional Genomics Center 
Zurich (FGCZ). 
RNA and real time qRT-PCR - RNA was 
extracted from frozen kidneys and real time qRT-
PCR was performed as previously described (3). 
Three samples per mouse and genotype were run 
and the abundance of the target mRNAs was 
calculated relative to Hypoxanthine Guanine 
Phosphoribosyltransferase (HPRT) or 
Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) as a reference. Relative expression 
ratios were calculated as R = 2(Ct(reference) – Ct(test)). Ct: 
cycle number at the threshold, test: tested mRNAs. 
Primers and probes were chosen as described 
elsewhere for B0AT1 (3), XT3 (3), SIT1 (3), XT2 
(3), ACE2 (12), Coll (5), GAPDH (3) and HPRT 
(13). 
Protein Preparation and Western blot Analysis 
- Oocyte homogenization and protein preparation 
was done as described previously (14). Surface 
labelling of oocytes expressing XT2 alone or co-
expressed with ACE2 or Collectrin using MTSEA-
Biotin (Sigma-Aldrich, Buchs Switzerland) and 
streptavidin precipitation were performed as 
previously described (15). For immuno-
precipitation, the lysate equivalent to 8 oocytes 
was coupled to 25 μl of anti-XT2 serum (3) in 
EBC solution (20 mM Tris-HCl pH 8.0, 120 mM 
NaCl, 0.5% NP40) for 8 h at 4°C on a rotator. The 
immunocomplexes were coupled to Immobilized 
Protein A/G beads (Pierce, Rockford, USA) O/N at 
4°C on a rotator. The beads were washed 6 times 
with NET-N solution (20 mM Tris-HCl pH 8.0, 
100 mM NaCl, 0.5% NP40, 1 mM EDTA), and the 
immunoprecipitate was eluted, denatured and 
reduced by heating at 95°C for 5 min in Laemmli 
Buffer. The equivalent of 2.4 oocytes was analysed 
by Western blotting. Brush Border Membrane 
Vesicles (BBMV) were prepared from whole 
mouse kidney using the Mg2+ precipitation 
technique as described elsewhere (15). 
Immunoblotting of the equivalent of 1 oocytes or 
20 μg of BBMVs was performed as described 
elsewhere (3). Primary antibodies were diluted 
(1:2000) for rabbit Affinity Purified (AP) anti-
B0AT1 (3) / anti-XT2 (3) / anti-XT3 (3), (1:2000) 
for guinea-pig serum anti-Coll (antigen peptide: 
NH2-VQSAIRKNRNRINSAC-CONH2 as in (16), 
Pineda, Berlin, Germany), (1:1000) for AP goat 
anti-mACE2 (R&D Systems, Minneapolis, USA), 
and (1:10000) for mouse anti-mb-actin (Sigma, St 
Louis, USA). Secondary antibodies were diluted 
(1:5000) for ECLTM Anti-rabbit IgG Horseradish 
Peroxidase linked fragment from donkey 
(Amersham Biosciences, Piscataway, USA), 
(1:10000) for Anti-guinea pig IgG Horseradish 
Peroxidase (Sigma) and (1:10000) for Anti-mouse 
IgG Alkaline Phosphatase Conjugate (Promega). 
Antibody binding was detected with Immobilon 
Western Chemiluminescent HRP or AP substrate 
(Millipore, Billerica, USA). Chemiluminescence 
was detected with a DIANA III camera (Raytest, 
Dietikon, Switzerland). For quantification relative 
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to b-actin, signal intensity was quantified with the 
AIDA Image Analyzer (Raytest). 
Organ fixation - Mice were anesthetized with 
ketamine and xylazine (90 mg/kg body weight, 
Narketan 10, Vétoquinol, Lure, France) and 
Xylazine (10 mg/kg body weight, Xylazin, Streuli, 
Uznach, Switzerland) intraperitoneally and 
perfused through the left cardiac ventricle with 
phosphate-buffered saline (PBS, 0.9% NaCl in 10 
mM phosphate buffer, pH 7.4) followed by a 
buffered paraformaldehyde solution (4%, pH 7), as 
previously described (17). Kidneys were then 
harvested, incubated overnight in 
paraformaldehyde solution, washed several times 
with PBS and stored in PBS-0.02% sodium azide 
at 4°C. Tissues were then mounted with Kryostat 
OCT (Medite, Nunningen, Switzerland), frozen in 
liquid propane and stored at - 80°C. 
Immunofluorescence - Immunofluorescence 
was performed as previously described (3). 
Primary antibodies were diluted (1:200) for rabbit 
Affinity Purified (AP) anti-mXT2 (3), (1:100) for 
AP goat anti-mACE2 (R&D), and (1:1000) for 
rabbit serum anti-mCollectrin  (antigen peptide: 
NH2-CDPLDMKGGHINDGFLT-CONH2 as in 
(16), Pineda). Secondary antibodies were diluted 
(1:500) for Alexa Fluor 594 donkey anti-rabbit 
IgG and Alexa Fluor 488 donkey anti-goat IgG 
(Molecular Probes, Invitrogen, Carlsbad, USA). 
For actin staining, Texas Red - X phalloidin 
(Molecular Probes) was diluted (1:500). Digital 
images were viewed using a Nikon Eclipse TE300 
epifluorescence microscope (Nikon Instruments 
Inc., Melville, USA) equipped with a DS-5M 
Standard CCD camera (Nikon) and acquired with 
NIS-Elements (Nikon). 
Telemetry measurement of blood pressure - 
Eight weeks old mice were anaesthetised (see 
Organ Fixation) and implanted with PA-C10 
transmitter (Data Sciences International (DSI), St. 
Paul, USA) through the carotid artery as 
previously described and following manufacturer 
information to place the pressure sensitive tip in 
the aortic arch (18,19). For analgesia purposes, 100 
μl of bupivacain hydrochloride 0.25% (Bucain, 
DeltaSelect GmbH Pfullingen, Germany) was 
injected directly in the wound at the end of the 
procedure and carprofenum (5mg/kg, Rimadyl, 
Pfizer, New York, USA) was injected 
subcutaneously every 12 h for 2 days. Twenty-four 
hours continuous measurements were recorded 
after 2 weeks of recovery with Dataquest ART 
version 3.1 and RespiRate (DSI). Systolic, 
diastolic and mean blood pressure, heart 
frequency, activity and respiratory rate were 
analysed separately for the light vs. dark phases 
and activity=0 vs. activity>0. To mimic tail-cuff 
manometry stress, mice were restrained during 20 
min in a perforated 50 ml Falcon tube, when the 
data was continuously measured. 
 
RESULTS 
 
Since XT2 has been shown to be associated in 
kidney proximal tubule with Coll (5), we tested the 
possibility that XT2 would be expressed 
functionally in X. laevis oocytes in the presence of 
this associated protein. XT2 was therefore co-
expressed in X. laevis oocytes with Coll and/or its 
homologue ACE2 and the uptake of L-isoleucine 
was tested. Unexpectedly, uptake of L-isoleucine 
was observed only when XT2 was co-expressed 
with ACE2, whereas no transport was observed 
when XT2 was expressed alone or together with 
Coll (Fig. 1A). Furthermore, co-expression of 
ACE2 and Coll with XT2 did not further increase 
the transport rate compared to XT2 + ACE2. 
The L-isoleucine transport induction upon 
ACE2 co-expression is accompanied by a slight 
increase of XT2 surface expression of 1.64 ± 0.39-
fold when compared to XT2 alone (Fig. 1B). 
Furthermore, co-immunoprecipitation of ACE2 
from oocyte membranes using XT2 antibody 
shows that ACE2 interacts with XT2 (Fig. 1C). 
These results suggest that ACE2 acts as a 
chaperone for XT2 slightly increasing its surface 
expression and more strongly its function in X. 
laevis oocytes. This co-expression renders the 
measurement of XT2 transport function possible in 
an expression system for the first time. 
XT2 co-expression with ACE2 allowed the 
characterization of its transport selectivity, 
showing the transport of a broad range of neutral 
amino acids (A, M, V, I > G, S, L) (Fig. 2A). 
Concentration-dependence experiments with L-Ile 
and Gly revealed a K0.5 of XT2 for these substrates 
(0.21 mM and 0.53 mM, respectively) that is lower 
than that of B0AT1 (Figs. 2B-C) (20). In contrast 
to B0AT1, but similarly to other members of the 
Slc6 family such as the GABA transporter GAT1 
(Slc6a1), the transport of L-Ile by XT2 is not only 
Na+- but also Cl--dependant as well as pH-
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independent (Figs. 2D-E). The Na+ dependence of 
Gly transport is sigmoidal with a Hill coefficient 
that is higher than one suggesting that more than 
one sodium molecule is involved (data not shown). 
The precise ion transport stoichiometry of XT2 
could not be investigated by two-electrode voltage 
clamp due to the low susbtrate transport rates 
To verify and examine the role of XT2 as an 
amino acid transporter more in detail, we re-
analysed the xt2 null mouse model (2) after more 
than 10 generations of backcrossing in C57BL/6 
background. To evaluate whether the lack of XT2 
induces compensatory changes, we examined the 
expression of the Slc6 family members B0AT1 and 
XT3 and of the associated proteins ACE2 and Coll 
at the mRNA and protein levels in xt2-/- mice but 
observed no difference with wild-type littermate 
controls (Supplemental Figs. 1A-B). 
To evaluate the impact of the loss of XT2 on 
the whole animal, we monitored food and water 
intake as well as urine and feces output in 
metabolic cages, but there were no differences in 
the measured parameters between the xt2+/+ and 
xt2-/- mice (Supplemental Table 1). Analysis 
of plasma amino acids only suggested a slight but 
statistically not significant decrease of glycine (G) 
and L-arginine (R) in the xt2-/- mice as compared 
to the xt2+/+ mice (Fig. 3A). A massive loss of 
glycine in the urine of the xt2-/- mice was 
confirmed and the loss of other neutral amino 
acids, notably L-glutamine (Q), was observed (Fig. 
3B). To compare the reabsorption of amino acids 
we estimated their fractional excretion. This is the 
proportion of the amino acids filtered by the 
kidney glomeruli that ends up in the urine (values 
of glomerular filtration rate were from (21)). 
Whereas the fractional excretion of L-glutamine 
was only slightly augmented to 2.94% in xt2 null 
mice, those of glycine and L-methionine (M) were 
strongly elevated to 51.37% and 33.41%, 
respectively (Table 1). These results show that 
despite aminoaciduria, these mice do not exhibit 
any compensatory mechanisms, implying that the 
normal diet readily provides excessive amounts of 
amino acids. The urinary peak corresponding to L-
arginine could unfortunately not be distinguished 
from that of taurine, preventing the evaluation of 
L-arginine loss in xt2 null mice. Challenging xt2 
null animals with a low protein diet (<0.5% crude 
protein) didn’t induce any additional difference in 
the metabolic cage parameters measured between 
xt2 null and wild-type mice (Supplemental Table 
1). 
To assess the situation of the different partners 
of XT2 in vivo, we first checked the localisation of 
XT2, Coll and ACE2 in mouse kidney. As 
previously shown, XT2 localises to the apical 
membrane in distal segments of the proximal 
tubule (S2,S3) and is not present in the initial S1 
segment that begins at the glomerulus (3) (Fig. 
4A). In contrast, ACE2 and Coll are both localised 
along the entire proximal tubule, but with opposed 
gradients increasing towards the distal and 
proximal tubular ends, respectively (Fig. 4A, 
Supplemental Table 2). This shows that the main 
site of ACE2 expression coincides with the 
localisation of XT2, suggesting that XT2 may 
interact with ACE2 in the proximal tubule, 
additionally to its known interaction with Coll (5). 
To test the role of these two potential 
associated proteins on XT2 expression in vivo, we 
used ace2 and coll null mice. At the mRNA level 
in kidney, XT2 expression was unchanged in coll 
null mice, as shown previously (5), and in ace2 
null mice (Fig. 4B). However, Western blot 
analysis of kidney brush border membrane proteins 
showed that XT2 was absent in the coll-/y mice, in 
contrast to ace2-/y and wild-type mice (Figs. 4C-
D). Immunofluorescence performed on kidney 
sections confirmed that XT2 is lacking in coll-/y 
mice proximal tubule, whereas it is normally 
expressed in ace2-/y as in wild-type control mice 
(Figs. 4E-F). Amino acid fractional excretions of 
ace2-/y and ace2+/y mice were compared to assess 
the impact of ACE2 on XT2 function (Table 1). 
The results indicate that amino acid handling was 
not significantly different in the kidney of ace2 
null mice compared to wild-type littermates. In 
contrast, aminoaciduria was very high in coll null 
mice, as reported previously (5). Note however 
that in these mice several other amino acid 
transporters are affected that contribute to the 
aminoaciduria. These results confirm that the 
partner of XT2 in mouse kidney is indeed Coll and 
not ACE2, despite the fact that the expression 
gradient of Coll along the proximal tubule is 
opposed to that of both XT2 and ACE2 and that 
Coll unlike ACE2 does not allow XT2 function in 
X. laevis oocytes. 
In the original study, xt2 null mice displayed, 
compared to wild-type littermates, a surprising 
elevation of blood pressure as measured by tail 
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cuff manometry. This difference was then 
abolished when drinking water was supplemented 
with glycine (0.1 g/ml) (2). The blood pressure of 
xt2 null mice was now retested using mice 
backcrossed more than 10 times into C57BL/6 
background and using telemetry (Datasciences). 
The measurements showed no differences in blood 
pressure between the xt2-/- and xt2+/+ mice during 
the light phase when mice were not active (Fig. 
5A). Similar results were obtained during the light 
and dark phases, whether the mice were active or 
not (data not shown). To test whether the 
previously measured increase in blood pressure 
was provoked by the stress of the tail cuff 
manometry method, telemetry measurements were 
repeated while physically restraining the mice. 
Submitting the animals to this stress provoked a 
higher mean blood pressure in xt2-/- mice than in 
wild-type littermates (130.8 ± 0.89 mmHg versus 
125.3 ± 1.40 mmHg), and also a higher respiratory 
rate (Fig. 5B). This suggests an increased stress-
induced reaction possibly involving a 
dysregulation of the sympathetic nervous system in 
xt2-/- mice. 
 
DISCUSSION 
 
The first aim of this study was to directly 
characterise the function of the orphan transporter 
XT2 in the X. laevis oocyte expression system 
using its in vivo associated protein Coll. However, 
not Coll but only its homologue ACE2 supported 
the functional expression of XT2 in X. laevis 
oocytes such that its transport function of neutral 
amino acids expected from its homology with 
B0AT1 could be measured. This raised the 
suggestion that ACE2 might interact with XT2 in 
mouse kidney in addition to Coll. However, our 
experiments with the ace2 and coll null mice 
confirmed that the in vivo partner of XT2 is Coll 
and not ACE2. Indeed XT2 expression and 
localisation is normal in the proximal kidney 
tubule of ace2 null mice and absent in coll null 
mice. Furthermore, the absence of ACE2 does not 
affect the reabsorption of amino acids, whereas 
that of Coll leads to a strong aminoaciduria that is 
due to the lack of expression of XT2 and of other 
proximal tubule amino acid transporters (5). These 
observations suggest that during evolution, Coll 
took over the role of ACE2 in amino acid transport 
due to the increasing involvement of the latter as a 
key player in the renin-angiotensin system. It is 
however not clear why the restriction of functional 
XT2 association with ACE2 or Coll is just 
opposite in X. laevis oocytes as compared to the in 
vivo situation in kidney. Surprisingly, it appears 
that the difference observed in X. laevis oocytes is 
species specific. Indeed, as suggested to us by S. 
Bröer (personal communication), co-expression of 
the human Coll ortholog with mouse XT2 
generates an uptake similar to that with mouse 
ACE2 (data not shown). Further experiments will 
be required to identify potential additional cell-
specific players that account for these differences. 
The functional expression of XT2 together 
with ACE2 in oocytes allowed the long sought 
characterisation of the function of this orphan 
transporter. Interestingly, its broad transport 
selectivity for neutral amino acids is clearly 
different from that of B0AT1. Particularly, whereas 
beta-branched amino acids are very good 
substrates for XT2, as it is the case for B0AT1, 
aromatic amino acids are apparently less 
efficiently transported. Importantly, L-Ala, L-Met, 
Gly, L-Ser and L-Cys are also efficiently 
transported. 
In contrast to B0AT1 that displays a Na+-
dependant electrogenic neutral amino acid 
transport, XT2 is shown here to display a transport 
mode that is not only Na+, but also Cl--dependant 
with a K0.5 for its preferred substrates that is lower 
than that of B0AT1. In that sense, the axial 
arrangement of XT2 that follows B0AT1 along the 
proximal tubule is similar to the sequential 
arrangement of low and high affinity glucose and 
peptide transporters SGLT2 and 1 and Pept1 and 2, 
respectively. 
To correlate the measured in vitro function of 
XT2 with its in vivo function we re-analysed the 
xt2 null mouse model. As the knock-out mice 
didn’t display compensatory changes of other 
amino acid transporters of the SLC6 cluster, or of 
associated proteins, we hypothesise that the 
urinary phenotype of xt2 null mice is essentially 
due to the absence of XT2. In accordance to the in 
vitro results we measured a broad aminoaciduria. 
Strikingly, there was not only a substantial loss of 
glycine (60-fold higher than in xt2+/+) but also of 
L-glutamine (20-fold) and of all other neutral 
amino acids (Fig. 3). XT2 thus appears to be 
required for reabsorbing the leftover tubular amino 
acids that have not been reabsorbed in the early 
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proximal kidney tubule segments by B0AT1 or the 
amino acids that would eventually backleak into 
the late proximal tubule segments through the 
paracellular route (22). Additionally, XT2 might 
also be required for the reabsorption of neutral 
amino acids that the luminal heterodimeric cystine 
and cationic amino acids transporter b0,+AT-rBAT 
releases in exchange for its uptake substrates in the 
tubular lumen. Thereby XT2 would interfere with 
L-arginine metabolism and nitric oxide (NO) 
synthesis (23). This latter hypothesis could be an 
explanation for the slightly decreased L-arginine 
plasma level and the tendency for elevated blood 
pressure observed in xt2 null mice.  
Interestingly, XT2 had originally been 
identified in rat kidney as a renal osmotic stress-
induced transcript (ROSIT) (24). However, the 
experiments that we performed in mice could not 
verify such a regulation (E. Romeo and F. Verrey, 
unpublished results). This is either due to a species 
difference or to the less drastic conditions that we 
used which might not have been sufficient to 
trigger this regulation. 
In their original description, xt2 null mice 
displayed a significantly elevated blood pressure 
(2). This was however not observed in the present 
study after backcrossing these mice 10 times in a 
C57BL/6 background and using a telemetry system 
for the blood pressure measurements. Previous 
reports have already evidenced discrepancies 
between tail cuff manometry and telemetric blood 
pressure measurements and also highlighted the 
importance of the genetic background. In 
particular, the original xt2 null mouse had Sv129 
genetic background, a strain that contains two 
renin genes and the renal blood flow of which was 
suggested to be more sensitive toward NO than 
that of C57BL/6 mice (25). We could however 
observe in the present study a stress-sensitive 
hypertension and a stress-induced increase in 
respiratory rate in xt2 null mice, suggesting a 
possible impact of the lack of this transporter on 
regulatory functions of the sympathetic nervous 
system. Interestingly, plasma L-arginine of xt2-/- 
mice was slightly lower than in the xt2+/+ mice and 
L-arginine is the precursor of nitric oxide that, 
when released by endothelial cells, leads to 
vasodilation. Slightly lower circulating and renal 
levels of L-arginine might therefore induce 
susceptibility to an increase in blood pressure (26). 
The role of XT2 in human seems to be limited 
since SLC6A18 has not been found associated 
with iminoglycinuria (R. Kleta, personal 
communication). Furthermore, a frequent SNP that 
leads to a stop codon in SLC6A18 has not been 
linked to increased blood pressure (4). However, it 
is not excluded that the individual variability in 
stress-induced blood pressure increase could be 
linked to the function of this renal neutral amino 
acid transporter. 
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FOOTNOTES 
 
ACE2:  Angiotensin-converting enzyme 2 
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Coll: Collectrin (Tmem27) 
BBMV: Brush border membrane vesicles 
HPRT: Hypoxanthine Guanine Phosphoribosyltransferase 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase 
 
 
FIGURE LEGENDS 
 
Fig. 1. XT2 and ACE2 functional interaction in vitro. A. Co-expression of ACE2 but not of Coll supports 
the function of XT2 in X. laevis oocytes. X. laevis oocytes were injected with 10 ng of each cRNA and 
incubated for 6 days. Na+-dependent uptake of L-Ile 0.1 mM (10 min) was assayed. The data represent 16-
24 oocytes from 2-4 independent experiments. Bars indicate mean value ± SEM. *** P<0.001. B. Surface-
biotinylated proteins of X. laevis oocytes injected with XT2 alone, co-expressed with Coll or with ACE2 
were analysed by Western blot using anti-XT2 antibody. The data correspond to the means ± SEM (n = 3). 
C. Total membranes of X. laevis oocytes were used for immunoprecipitation with an anti-XT2 antibody 
and immunocomplexes were analysed by Western blot with anti-ACE2 antibody. 
 
Fig. 2. Transport selectivity and kinetics of XT2 co-expressed with ACE2. A. Substrate selectivity of XT2 
co-expressed with ACE2 in X. laevis oocytes. Na+-Cl--dependant uptake selectivity of L-AA (0.1 mM) 
was assayed for 10 min. Amino acids are abbreviated with the single letter code. B, C. Concentration 
dependence of the XT2-ACE2 mediated transport in oocytes. Curves corresponding to Michaelis-Menten 
kinetics were fitted to Na+-Cl--dependant uptake of L-Ile (B) and Gly (C). Data represent means of 18-39 
oocytes ± SEM from 3-5 independent experiments. D. Transport induced by XT2 co-expressed with 
ACE2 is Na+- and Cl--dependant. Data are means of 13-16 oocytes ± SEM from two independent 
experiments. E. Transport of L-Ile was not influenced by pH. The transport of L-Ile was assayed in the 
presence of Na+ and Cl- at different pH’s. Means from 8 oocytes ± SEM. Open bars show transport rate of 
XT2-, black bars of XT2+ACE2- and grey bars of ACE2-expressing oocytes (D, E). 
 
Fig. 3. The xt2 null mice have increased levels of neutral amino acids in urine, and a slight but not 
significant decrease of plasma glycine (G) and L-arginine (R). Plasma (A) and urine (B) of xt2+/+ and xt2-/- 
mice was deproteinized and analysed by HPLC. Bars indicate mean values ± SEM, n=7 (A) and n=6 (B) 
mice per genotype. *P<0.05, ** P<0.01, *** P<0.001. ND: not determined. 
 
Fig. 4. Lack of XT2 in coll-/y but not in ace2-/y mouse kidney. A. Immunofluorescence of wild-type kidney 
co-labelled with XT2 and ACE2, and on a consecutive section co-labelled with Coll and Actin. G: 
glomerulus. B. Real time RT-PCR of XT2 and Coll on ace2+/y and ace2-/y total kidney RNA. Bars indicate 
mean value ± SEM, n=3 mice per genotype. C, D. Kidney brush border membrane vesicles (BBMV) (20 
μg) from coll+/y and coll-/y mice (C) and ace2+/y and ace2-/y mice (D) were analysed by Western blot using 
antibodies against XT2, Coll (with a specific signal at 42 kDa, see supplemental data), ACE2, and β-actin 
(βa). Each lane corresponds to material prepared from one mouse. Immunofluorescence of coll-/y kidney 
co-labelled with XT2 and ACE2 (E), and ace2-/y kidney labelled with XT2 and on a consecutive section 
with Coll (F). Immunofluorescence experiments were performed at least three times with similar results 
for each antibody. Representative images are shown in the figures. As shown also by Western blot in C, 
D, XT2 expression is lacking in kidney of coll null mice, whereas it is expressed in ace2 null mice. 
 
Fig. 5. The xt2 null mice display a stress-induced increase of blood pressure and respiratory rate. The 
xt2+/+ and xt2-/- mice were implanted with blood pressure telemetry sensors (DSI). Mean pressure, pulse 
pressure, heart rate (BPM: beats per minute) and respiratory rate (RCPM: Respiratory Cycle Per Minute) 
of xt2+/+ and xt2-/- mice during the light period, when the mice were not active (A) or during a 20 min 
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 5, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
SLC6A18 is neutral amino acid transporter B0AT3 
 
 10
physical restrain stress (B). Bars indicate mean values ± SEM, n=7 mice per genotype. *P<0.05, ** 
P<0.01. 
 
 
 Table 1. Fractional urinary amino acid excretion  
1Fractional excretion was calculated using an estimate of the glomerular filtration rate of 150 μl/min in 
females and 240 μl/min in males (21), the measured amino acid concentrations in plasma and urine and 
the volume of urine excreted over 24 h. 2ND: not determined. 3Males n=3, females n=3. 4Males n=5. 
5Males n=3 
 
  
1Fractional            excretion (%) 
  
 3xt2+/+ xt2-/- 
fold 
change  4ace2+/y ace2-/y 
fold 
change  5coll+/y coll-/y 
fold 
change 
G 0.53 51.37 96.25  0.73 0.51 0.69  1.95 82.13 42.19 
A 0.59 4.49 7.60  0.43 0.69 1.61  0.60 56.42 94.47 
V 0.33 3.50 10.75  0.13 0.07 0.51  0.21 26.36 125.00 
L 1.23 11.71 9.50  0.45 0.25 0.56  1.55 54.56 35.22 
I 2.30 8.97 3.90  0.39 0.15 0.37  0.41 36.45 88.31 
M 5.00 33.41 6.68  1.61 1.19 0.74  6.20 58.52 9.43 
S 0.47 6.66 14.07  2.48 1.77 0.72  1.99 77.69 39.00 
T 1.04 7.33 7.06  0.57 0.35 0.61  1.55 114.24 73.78 
C 2ND ND ND  ND ND ND  ND ND ND 
P 0.33 0.59 1.79  1.71 1.13 0.66  0.46 65.93 144.59 
N 2.91 6.76 2.33  ND ND ND  ND ND ND 
Q 0.11 2.94 26.72  0.32 0.32 1.00  0.36 63.69 177.61 
F 0.39 5.87 15.21  0.87 0.67 0.77  0.52 21.25 40.83 
Y 0.34 2.14 6.38  0.61 0.49 0.80  1.70 16.45 9.70 
W 1.97 4.24 2.16  0.30 0.39 1.30  10.99 22.78 2.07 
K 1.58 2.98 1.88  0.10 0.09 0.88  2.46 4.50 1.83 
R ND ND ND  ND ND ND  ND ND ND 
H 1.74 9.66 5.56  1.25 1.11 0.89  ND ND ND 
D 2.62 4.12 1.57  ND ND ND  ND ND ND 
E 11.46 16.03 1.40  4.05 3.61 0.89  2.17 6.52 3.01 
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Orphan transporter SLC6A18 is renal neutral amino acid transporter B0AT3  
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Supplemental Table 1. Summary of metabolic cage and urine data from male and female mice. 
Male and female mice were fed a normal protein diet (A. 18.5 %, 2 d), a low protein diet (B. <0.5 %, 2 d) 
or were deprived of water (C. 24 h) A. Males n=9, females n=8, total n=17. B. Males n=4, females n=5, 
total n=9. C. Males n=5, females n=3, total n=8. Data indicate means ± SEM. Urinary excretion was 
normalized to creatinine (crea). BW: body weight. ND: not determined. 
 
 ANormal protein diet (2 d) BLow protein diet (2 d) CWater deprivation (24 h) 
 xt2+/+ xt2-/- xt2+/+ xt2-/- xt2+/+ xt2-/- 
Males body weight 
(g) 25.28±0.39 25.62±0.51 22.98±0.50 23.73±0.33 23.36±0.19 23.08±0.75 
Females body 
weight (g) 21.65±0.43 21.65±0.39 20.28±0.09 20.44±0.35 19.17±0.82 18.93±0.65 
Males and females :      
Food (g/g BW) 0.155±0.0075 0.158±0.008 0.142±0.005 0.147±0.003 0.110±0.010 0.113±0.005 
Water (ml/g BW) 0.24±0.02 0.22±0.01 0.45±0.05 0.39±0.05 0 0 
Feces (g/g BW) 0.056±0.004 0.053±0.005 0.018±0.004 0.018±0.002 0.0322±0.003 0.0310±0.002
Urine (ml/g BW) 0.031±0.005 0.039±0.005 0.200±0.026 0.162±0.023 0.012±0.003 0.018±0.003 
Creatinine (mM) 5.44 ± 0.42  5.18 ± 0.34 1.40 ± 0.17 1.39 ± 0.17 6.55 ± 0.61  5.49 ± 0.21 
Osmolality 
(mOsm/kg) 3266±209 3079±14 457.3±44.2 509.8±47.0 4680±356 4540±377 
pH 6.23±0.07 6.28±0.12 6.22±0.14 6.27±0.06 ND ND 
Na+/crea 33.08±4.08 38.44±4.71 81.93±5.20 122.9±21.4 44.11±7.38 41.91±8.60 
K+/crea 112.9±13.0 122.2±14.8 58.02±5.19 78.99±11.29 127.8±2.285 111.1±11.66 
Ca2+/crea 0.97±0.24 1.08±0.22 3.15±1.193 2.26±0.25 0.36±0.07 0.28±0.07 
Mg2+/crea 10.25 ± 1.11 11.44 ± 1.56 8.10 ± 0.73 10.19 ± 1.56 8.76 ± 0.50 9.52 ± 0.73 
Cl-/crea 58.78 ± 1.90 60.15 ± 2.55 83.54 ± 2.72 100.4 ± 12.12 135.9 ± 21.12 154.5 ± 26.59 
PO42-/crea 9.03 ± 0.64 10.05 ± 1.23 28.62 ± 1.61 30.56 ± 1.58 31.50 ± 5.24 27.18 ± 4.34 
SO42-/crea 14.34 ± 0.87 14.13 ± 0.74 4.82 ± 0.48 4.83 ± 0.38 24.82 ± 2.71 28.62 ± 5.06 
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Supplemental Table 2. Immunofluorescence quantification in early (S1) and late (S3) segments of the 
proximal tubule show opposing axial gradients of Coll and ACE2. XT2 and B0AT1 were quantified as 
controls. Brush border staining was quantified (intensity/area) in early proximal tubule (after the 
narrowing of Bowman’s capsule) and late proximal tubule (long straight segments towards the medulla) 
with AnalySIS 5 (SoftImaging System, Munster, Germany). A 100% staining was set in the segments with 
the strongest signal for each antibody. The analysis was performed for 2-4 animals with 2-3 early and late 
proximal tubule segments per section for each antibody. Picture acquisition conditions were kept constant 
between the regions of a same kidney section.  
 
 
Signal intensity 
(%) 
 Proximal tubule 
 early late 
Coll 100.00 51.19 
ACE2 56.23 100.00 
XT2 0.00 100.00 
B0AT1 100.00 0.00 
 
 
Supplemental Fig. 1. Absence of compensatory regulation of other renal SLC6 amino acid transporters or 
associated proteins in xt2 null mice. A. Real time RT-PCR of B0AT1, XT3 (Slc6a20a) and SIT1 
(Slc6a20b) on ace2+/y and ace2-/y total kidney RNA. Bars indicate mean value ± SEM, n=2 mice per 
genotype. B. Western blot analysis on kidney BBMV (20 μg) from xt2+/+ and xt2-/- mice using antibodies 
against B0AT1, XT3, ACE2, Coll, and β-actin (βa). 
 
 
Supplemental Fig. 2. Specificity of the guinea-pig serum anti-Coll was tested on coll+/y and coll-/y 
BBMVs with and without deglycosylation (PNGase F). A specific signal is detected around 40 kDa. 
Hydrolysis of Asn-oligosaccharides was carried out using endo-beta-N-acetylglucosaminidase F enzyme 
(PNGase F) (New England Biolabs, USA). 
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